1. Home
  2. ELTX vs FOSL Comparison

ELTX vs FOSL Comparison

Compare ELTX & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • FOSL
  • Stock Information
  • Founded
  • ELTX 2011
  • FOSL 1984
  • Country
  • ELTX United States
  • FOSL United States
  • Employees
  • ELTX N/A
  • FOSL N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • FOSL Consumer Specialties
  • Sector
  • ELTX Health Care
  • FOSL Consumer Discretionary
  • Exchange
  • ELTX Nasdaq
  • FOSL Nasdaq
  • Market Cap
  • ELTX 49.7M
  • FOSL 55.3M
  • IPO Year
  • ELTX 2021
  • FOSL 1993
  • Fundamental
  • Price
  • ELTX $4.16
  • FOSL $1.22
  • Analyst Decision
  • ELTX Buy
  • FOSL
  • Analyst Count
  • ELTX 2
  • FOSL 0
  • Target Price
  • ELTX $10.00
  • FOSL N/A
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • FOSL 196.4K
  • Earning Date
  • ELTX 11-07-2024
  • FOSL 11-07-2024
  • Dividend Yield
  • ELTX N/A
  • FOSL N/A
  • EPS Growth
  • ELTX N/A
  • FOSL N/A
  • EPS
  • ELTX N/A
  • FOSL N/A
  • Revenue
  • ELTX N/A
  • FOSL $1,280,256,000.00
  • Revenue This Year
  • ELTX N/A
  • FOSL N/A
  • Revenue Next Year
  • ELTX N/A
  • FOSL N/A
  • P/E Ratio
  • ELTX N/A
  • FOSL N/A
  • Revenue Growth
  • ELTX N/A
  • FOSL N/A
  • 52 Week Low
  • ELTX $2.96
  • FOSL $0.75
  • 52 Week High
  • ELTX $11.45
  • FOSL $1.83
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • FOSL 50.18
  • Support Level
  • ELTX $4.05
  • FOSL $1.13
  • Resistance Level
  • ELTX $4.89
  • FOSL $1.19
  • Average True Range (ATR)
  • ELTX 0.28
  • FOSL 0.05
  • MACD
  • ELTX -0.06
  • FOSL -0.01
  • Stochastic Oscillator
  • ELTX 27.37
  • FOSL 40.00

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Share on Social Networks: